SXSW 2024
Psychedelics for Mental Health: A Framework for the Future
Description:
In recent years, psychedelic treatments have exploded in popularity and interest. Despite the hype, there are numerous unanswered questions and controversies that remain to be addressed, including proper dosing, best routes to establish efficacy, necessity of the subjective psychedelic experience for clinical benefit, mechanism of action, role of psychotherapy in the treatment, optimal methods of preparation and aftercare, and routes to establishing personalized treatment approaches. This panel will provide a state-of-the-art overview of these issues as well as a framework for future progress.
Related Media
Takeaways
- The role of psychotherapy in psychedelic treatment remains untested/unoptimized. Research is needed to establish if/how it contributes to benefits.
- Knowledge of the key mechanisms of action, from neuronal plasticity to brain networks to noetic insights, will contribute to optimizing treatments.
- Combining psychedelics with other efficacious treatments, e.g., evidence-based psychotherapy and neuromodulation, may enhance clinical benefits.
Speakers
- Gregory Fonzo, Assistant Professor and Co-Director, Center for Psychedelic Research and Therapy, The University of Texas at Austin Dell Medical School
- Charles Nemeroff, Co-Director, Professor, and Chairman, Center for Psychedelic Research and Therapy, The University of Texas at Austin Dell Medical School
- Justin LaPree, Founder/President, Heroic Path to Light
- Lief Fenno, Assistant Professor, The University of Texas at Austin Dell Medical School
Organizer
Gregory Fonzo, Assistant Professor And Co-Director, Center for Psychedelic Research and Therapy, The University of Texas at Austin Dell Medical School
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments